These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 22242645

  • 1. Bioequivalence of two omega-3 fatty acid ethyl ester formulations: a case of clinical pharmacology of dietary supplements.
    Galli C, Maggi FM, Risé P, Sirtori CR.
    Br J Clin Pharmacol; 2012 Jul; 74(1):60-5. PubMed ID: 22242645
    [Abstract] [Full Text] [Related]

  • 2. Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers.
    Rusca A, Di Stefano AF, Doig MV, Scarsi C, Perucca E.
    Eur J Clin Pharmacol; 2009 May; 65(5):503-10. PubMed ID: 19148629
    [Abstract] [Full Text] [Related]

  • 3. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K, Kralovec J, Bailey-Hall E, Smeberg V, Stark JG, Salem N.
    Lipids Health Dis; 2015 Sep 02; 14():99. PubMed ID: 26328782
    [Abstract] [Full Text] [Related]

  • 4. Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study.
    Offman E, Marenco T, Ferber S, Johnson J, Kling D, Curcio D, Davidson M.
    Vasc Health Risk Manag; 2013 Sep 02; 9():563-73. PubMed ID: 24124374
    [Abstract] [Full Text] [Related]

  • 5. A novel self-micro-emulsifying delivery system (SMEDS) formulation significantly improves the fasting absorption of EPA and DHA from a single dose of an omega-3 ethyl ester concentrate.
    Qin Y, Nyheim H, Haram EM, Moritz JM, Hustvedt SO.
    Lipids Health Dis; 2017 Oct 16; 16(1):204. PubMed ID: 29037249
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Minimal food effect for eicosapentaenoic acid and docosahexaenoic acid bioavailability from omega-3-acid ethyl esters with an Advanced Lipid TechnologiesTM (ALT®)-based formulation.
    Lopez-Toledano MA, Thorsteinsson T, Daak AA, Maki KC, Johns C, Rabinowicz AL, Sancilio FD.
    J Clin Lipidol; 2017 Oct 16; 11(2):394-405. PubMed ID: 28502496
    [Abstract] [Full Text] [Related]

  • 13. Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers.
    Offman E, Davidson M, Abu-Rashid M, Chai P, Nilsson C.
    Eur J Drug Metab Pharmacokinet; 2017 Oct 16; 42(5):815-825. PubMed ID: 28116646
    [Abstract] [Full Text] [Related]

  • 14. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations--a comparative bioavailability study of fish oil vs. krill oil.
    Schuchardt JP, Schneider I, Meyer H, Neubronner J, von Schacky C, Hahn A.
    Lipids Health Dis; 2011 Aug 22; 10():145. PubMed ID: 21854650
    [Abstract] [Full Text] [Related]

  • 15. Bioavailability of marine n-3 fatty acid formulations.
    Dyerberg J, Madsen P, Møller JM, Aardestrup I, Schmidt EB.
    Prostaglandins Leukot Essent Fatty Acids; 2010 Sep 22; 83(3):137-41. PubMed ID: 20638827
    [Abstract] [Full Text] [Related]

  • 16. A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid TechnologiesTM (ALT®) Improves Docosahexaenoic Acid and Eicosapentaenoic Acid Bioavailability Compared with Lovaza®.
    Lopez-Toledano MA, Thorsteinsson T, Daak A, Maki KC, Johns C, Rabinowicz AL, Sancilio FD.
    Clin Ther; 2017 Mar 22; 39(3):581-591. PubMed ID: 28189364
    [Abstract] [Full Text] [Related]

  • 17. Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study.
    Dunbar RL, Gaudet D, Davidson M, Rensfeldt M, Yang H, Nilsson C, Kvarnström M, Oscarsson J.
    Lipids Health Dis; 2020 May 30; 19(1):117. PubMed ID: 32473640
    [Abstract] [Full Text] [Related]

  • 18. Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans.
    Ostermann AI, West AL, Schoenfeld K, Browning LM, Walker CG, Jebb SA, Calder PC, Schebb NH.
    Am J Clin Nutr; 2019 May 01; 109(5):1251-1263. PubMed ID: 31006007
    [Abstract] [Full Text] [Related]

  • 19. The enteral bioavailability of eicosapentaenoic acid and docosahexaenoic acid is as good from ethyl esters as from glyceryl esters in spite of lower hydrolytic rates by pancreatic lipase in vitro.
    Krokan HE, Bjerve KS, Mørk E.
    Biochim Biophys Acta; 1993 May 20; 1168(1):59-67. PubMed ID: 8504143
    [Abstract] [Full Text] [Related]

  • 20. Strategies to improve bioavailability of omega-3 fatty acids from ethyl ester concentrates.
    Maki KC, Dicklin MR.
    Curr Opin Clin Nutr Metab Care; 2019 Mar 20; 22(2):116-123. PubMed ID: 30550388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.